Global health care company Merck & Co., Inc. (NYSE:MRK) announced that it struck a definite agreement to buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX), a bio-pharmaceutical company, for $3.85 billion. The acquisition is expected to help Merck widen its portfolio on Hepatitis C. Merck & Co., Inc. (NYSE:MRK) stock opened today at $57.92 and is currently trading at $58.15. The stock showed a positive weekly performance of 0.02%.
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) said its Phase IIIb clinical study evaluating the efficacy and safety of the investigational product AVP-825 22mg to sumatriptan 100mg tablets for the treatment of acute migraines in adults, met its primary endpoint. Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) stock opened at $5.58, in current trading session and currently is at $5.47, by gaining 2.43%. The 52 week range of $2.62 – $6.00. Company’s market capitalization is 874.27 million.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) on 2 June reported data from its ongoing Phase 1 study of the fully human monoclonal antibody varlilumab (CDX-1127) in cancer. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock is currently trading at $16.75. The EPS of the stock is -1.12. Company’s market capitalization is 1.50 billion.
Spherix Inc. (NASDAQ:SPEX) announced Tuesday that its Texas wholly owned subsidiary, NNPT LLC, has commenced patent litigation in the United States District Court for the Eastern District of Texas against Huawei Device USA Inc.; Huawei Technologies USA Inc.; Huawei Technologies Cooperatif U.A. and Futurewei Technologies Inc. Spherix Inc. (NASDAQ:SPEX) stock opened the session at $1.97, and now is at $1.83. The 52 week range of the Spherix Inc. (NASDAQ:SPEX) stock remained $1.19 – $27.86 and the day range was $1.80 – $1.97.
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) a specialty pharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) has issued a US patent term extension certificate extending the term of US Patent No. 6,599,498 by 1,209 days. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened today at $17.91 and is currently trading at $18.10. The stock showed a negative weekly performance of -0.06%.